- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Diagnostic Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Diagnostic Radiopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 5146.6 million by 2025, from USD 3985.1 million in 2019.
Market segmentation
Diagnostic Radiopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diagnostic Radiopharmaceuticals market has been segmented into
Technetium 99
Fluorine 18
Other
By Application, Diagnostic Radiopharmaceuticals has been segmented into:
Oncology
Cardiology
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Radiopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Radiopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Radiopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Diagnostic Radiopharmaceuticals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Diagnostic Radiopharmaceuticals Market Share Analysis
Diagnostic Radiopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Radiopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Radiopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Diagnostic Radiopharmaceuticals are:
Cardinal Health
China Isotope & Radiation
Jubilant Pharma
GE Healthcare
SIEMENS
Curium Pharma
Lantheus
Advanced Accelerator Applications
Bracco Imaging
Dongcheng Pharmaceutical Group
Eli Lilly
Among other players domestic and global, Diagnostic Radiopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostic Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diagnostic Radiopharmaceuticals, with price, sales, revenue and global market share of Diagnostic Radiopharmaceuticals in 2018 and 2019.
Chapter 3, the Diagnostic Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Diagnostic Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Diagnostic Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Diagnostic Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diagnostic Radiopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Diagnostic Radiopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Overview of Global Diagnostic Radiopharmaceuticals Market
1.4.1 Global Diagnostic Radiopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cardinal Health
2.1.1 Cardinal Health Details
2.1.2 Cardinal Health Major Business
2.1.3 Cardinal Health SWOT Analysis
2.1.4 Cardinal Health Product and Services
2.1.5 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 China Isotope & Radiation
2.2.1 China Isotope & Radiation Details
2.2.2 China Isotope & Radiation Major Business
2.2.3 China Isotope & Radiation SWOT Analysis
2.2.4 China Isotope & Radiation Product and Services
2.2.5 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Jubilant Pharma
2.3.1 Jubilant Pharma Details
2.3.2 Jubilant Pharma Major Business
2.3.3 Jubilant Pharma SWOT Analysis
2.3.4 Jubilant Pharma Product and Services
2.3.5 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business
2.4.3 GE Healthcare SWOT Analysis
2.4.4 GE Healthcare Product and Services
2.4.5 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 SIEMENS
2.5.1 SIEMENS Details
2.5.2 SIEMENS Major Business
2.5.3 SIEMENS SWOT Analysis
2.5.4 SIEMENS Product and Services
2.5.5 SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Curium Pharma
2.6.1 Curium Pharma Details
2.6.2 Curium Pharma Major Business
2.6.3 Curium Pharma Product and Services
2.6.4 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lantheus
2.7.1 Lantheus Details
2.7.2 Lantheus Major Business
2.7.3 Lantheus Product and Services
2.7.4 Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Advanced Accelerator Applications
2.8.1 Advanced Accelerator Applications Details
2.8.2 Advanced Accelerator Applications Major Business
2.8.3 Advanced Accelerator Applications Product and Services
2.8.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bracco Imaging
2.9.1 Bracco Imaging Details
2.9.2 Bracco Imaging Major Business
2.9.3 Bracco Imaging Product and Services
2.9.4 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dongcheng Pharmaceutical Group
2.10.1 Dongcheng Pharmaceutical Group Details
2.10.2 Dongcheng Pharmaceutical Group Major Business
2.10.3 Dongcheng Pharmaceutical Group Product and Services
2.10.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Product and Services
2.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Diagnostic Radiopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Diagnostic Radiopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Diagnostic Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Diagnostic Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Diagnostic Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Diagnostic Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Diagnostic Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Diagnostic Radiopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Diagnostic Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Diagnostic Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Diagnostic Radiopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Diagnostic Radiopharmaceuticals Price by Type (2015-2020)
11 Global Diagnostic Radiopharmaceuticals Market Segment by Application
11.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Diagnostic Radiopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Diagnostic Radiopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Diagnostic Radiopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Diagnostic Radiopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Diagnostic Radiopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Diagnostic Radiopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Diagnostic Radiopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Diagnostic Radiopharmaceuticals Market Forecast (2021-2025)
12.3 Diagnostic Radiopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Diagnostic Radiopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Radiopharmaceuticals Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Diagnostic Radiopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 9. Cardinal Health Diagnostic Radiopharmaceuticals Major Business
Table 10. Cardinal Health Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 11. Cardinal Health SWOT Analysis
Table 12. Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
Table 13. Cardinal Health Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 15. China Isotope & Radiation Diagnostic Radiopharmaceuticals Major Business
Table 16. China Isotope & Radiation Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 17. China Isotope & Radiation SWOT Analysis
Table 18. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
Table 19. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Jubilant Pharma Diagnostic Radiopharmaceuticals Major Business
Table 22. Jubilant Pharma Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 23. Jubilant Pharma SWOT Analysis
Table 24. Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 25. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 27. GE Healthcare Diagnostic Radiopharmaceuticals Major Business
Table 28. GE Healthcare Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 29. GE Healthcare SWOT Analysis
Table 30. GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
Table 31. GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 33. SIEMENS Diagnostic Radiopharmaceuticals Major Business
Table 34. SIEMENS Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 35. SIEMENS SWOT Analysis
Table 36. SIEMENS Diagnostic Radiopharmaceuticals Product and Services
Table 37. SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Curium Pharma Diagnostic Radiopharmaceuticals Major Business
Table 40. Curium Pharma Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 41. Curium Pharma SWOT Analysis
Table 42. Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
Table 43. Curium Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Lantheus Basic Information, Manufacturing Base and Competitors
Table 45. Lantheus Diagnostic Radiopharmaceuticals Major Business
Table 46. Lantheus Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 47. Lantheus SWOT Analysis
Table 48. Lantheus Diagnostic Radiopharmaceuticals Product and Services
Table 49. Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 51. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Major Business
Table 52. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 53. Advanced Accelerator Applications SWOT Analysis
Table 54. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product and Services
Table 55. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 57. Bracco Imaging Diagnostic Radiopharmaceuticals Major Business
Table 58. Bracco Imaging Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 59. Bracco Imaging SWOT Analysis
Table 60. Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
Table 61. Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 63. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Major Business
Table 64. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 65. Dongcheng Pharmaceutical Group SWOT Analysis
Table 66. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product and Services
Table 67. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 69. Eli Lilly Diagnostic Radiopharmaceuticals Major Business
Table 70. Eli Lilly Diagnostic Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 71. Eli Lilly SWOT Analysis
Table 72. Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
Table 73. Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Diagnostic Radiopharmaceuticals Sales by Manufacturer (2018-2019) (K Units)
Table 75. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Diagnostic Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)
Table 77. Global Diagnostic Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 78. Global Diagnostic Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Diagnostic Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 80. North America Diagnostic Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 81. North America Diagnostic Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 83. Europe Diagnostic Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 84. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 85. Europe Diagnostic Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Diagnostic Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)
Table 87. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Diagnostic Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 90. South America Diagnostic Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 91. South America Diagnostic Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 94. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 97. Global Diagnostic Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 98. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 99. Global Diagnostic Radiopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 100. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 101. Global Diagnostic Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 102. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 103. Global Diagnostic Radiopharmaceuticals Sales Forecast by Regions (2021-2025) (K Units)
Table 104. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 105. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2025) (K Units)
Table 106. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 107. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2025)
Table 108. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Picture
Figure 2. Global Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2019
Figure 3. Technetium 99 Picture
Figure 4. Fluorine 18 Picture
Figure 5. Other Picture
Figure 6. Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 7. Oncology Picture
Figure 8. Cardiology Picture
Figure 9. Other Picture
Figure 10. Global Diagnostic Radiopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Diagnostic Radiopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 31. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Diagnostic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Diagnostic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 38. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Regions in 2018
Figure 39. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 40. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 42. South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 44. North America Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Diagnostic Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 46. North America Diagnostic Radiopharmaceuticals Sales Market Share by Countries in 2018
Figure 47. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Countries in 2018
Figure 49. United States Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 55. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Regions 2019
Figure 63. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Diagnostic Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 70. South America Diagnostic Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 71. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Diagnostic Radiopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Diagnostic Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Diagnostic Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Diagnostic Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Diagnostic Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Diagnostic Radiopharmaceuticals Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
